Home » Prolia Has Potential for Prominent Share of the Osteoporosis Market
Prolia Has Potential for Prominent Share of the Osteoporosis Market
A study published this week by Majestic Research found that physicians plan to ramp up use of Amgen’s Prolia in spite of pricing and reimbursement concerns.
Earth Times
Earth Times
Upcoming Events
-
07May
-
14May
-
30May